Nicotine Patch Suppliers & Bulk Manufacturers
Available Forms: Patches
Available Strengths: 7 mg, 14 mg, 21 mg patches
Reference Brands: Nicoderm CQ
Category:
Transdermal Patches
Nicotine patches release controlled nicotine to stimulate brain receptors, reducing withdrawal symptoms and cravings. They support smoking cessation, improve health, and lower addiction risks. Benefits include gradual dose reduction, fewer withdrawal symptoms, increased success rates, and safer withdrawal support, aiding long-term quitting efforts.
Nicotine Patch is available in Patches
and strengths such as 7 mg, 14 mg, 21 mg patches.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nicotine Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nicotine Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nicotine patches in the EU and US are regulated as medical devices supporting smoking cessation. In the US, FDA approval involves validation, safety validation, and GMP standards. In the EU, CE marking certifies conformity under MDR standards. These products undergo validation, stability testing, and audits, supported by detailed dossiers including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective nicotine replacement therapy devices, supporting smoking cessation efforts worldwide, reducing tobacco-related health risks, and promoting healthier lifestyles through regulated, high-quality products.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing